AI Article Synopsis

  • - The study aimed to evaluate how often vascular events occur in patients with head and neck cancer, reviewing 146 primary studies up to April 2023.
  • - Out of over 1.18 million patients analyzed, about 4.3% experienced a vascular event, with radiation therapy presenting the highest risk compared to surgery and chemotherapy.
  • - The findings suggest that routine anticoagulation isn't necessary for these patients, indicating that vascular events affect 4%-5% of them, particularly those receiving radiation treatment.

Article Abstract

Objective: To assess the incidence of vascular events in patients with head and neck cancer.

Review Methods: Primary studies identified through April 2023. Meta-analysis was performed.

Results: There were 146 studies included in the systematic review. Rates of events were collected in the overall group, those with chemoprophylaxis, and those that underwent surgery, radiation, or chemotherapy. Of 1 184 160 patients, 4.3% had a vascular event. Radiation therapy had highest risk of overall events and stroke when compared to surgery and chemotherapy. Chemotherapy had a higher risk of stroke and overall events when compared to surgery.

Conclusions: Vascular events occur in 4%-5% of patients with head and neck cancer. Our data does not support the use of routine anticoagulation. Patients undergoing radiation therapy had the highest frequency of events.

Download full-text PDF

Source
http://dx.doi.org/10.1002/hed.27675DOI Listing

Publication Analysis

Top Keywords

vascular events
12
patients head
12
head neck
12
events patients
8
neck cancer
8
systematic review
8
radiation therapy
8
therapy highest
8
events
6
patients
5

Similar Publications

Aims: This study aims to verify the feasibility and safety of percutaneous coronary intervention (PCI) after a distal transradial approach (dTRA) with radial artery occlusion (RAO) recanalization.

Methods: Between July 2018 and January 2022, 30 patients underwent PCI following attempted RAO recanalization via dTRA. Among these cases, the target radial arteries could not be recanalized in five patients, necessitating alternative vascular access.

View Article and Find Full Text PDF

The cascade of events leading to tumor formation includes induction of a tumor supporting neovasculature, as a primary hallmark of cancer. Developing vasculature is difficult to evaluate but can be captured using microfluidic chip technology and patient derived cells. Herein, we established an approach to investigate the mechanisms promoting tumor vascularization and vascular targeted therapies via co-culture of cancer spheroids and endothelial cells in a three dimensional environment.

View Article and Find Full Text PDF

Safety and efficacy of chocolate balloon in the treatment of infrapopliteal artery disease.

CVIR Endovasc

January 2025

Department of Vascular Surgery, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.

Objective: To evaluate the safety and efficacy of chocolate balloons in patients with chronic limb-threatening ischemia (CLTI) and infrapopliteal artery disease, and compare them with conventional balloons.

Methods: This single-center retrospective study included 167 patients with CLTI and infrapopliteal who underwent endovascular intervention with or without chocolate balloons from September 1, 2019 to June 30, 2023. The primary endpoint was amputation-free survival (AFS).

View Article and Find Full Text PDF

Background: Limited data exist on the impact of polyvascular disease (PolyVD) on clinical outcomes in female patients undergoing transcatheter aortic valve replacement (TAVR). We therefore sought to investigate clinical outcomes in women with versus without PolyVD undergoing TAVR.

Methods: Female participants from the multicentre Women's International Transcatheter Aortic Valve Implantation (WIN-TAVI) registry were categorized based on the presence or absence of PolyVD.

View Article and Find Full Text PDF

Introduction: Carotid IMT is a recognized marker for early atherosclerotic changes and a predictor of future CV events. Previous studies showed 11% increased risk of myocardial infarction with each 0.1 mm incremental increase of carotid IMT.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!